Vertex Pharmaceuticals Incorporated (BMV:VRTX)
8,300.29
+512.78 (6.58%)
At close: Dec 3, 2025
-11.36% (1Y)
| Market Cap | 2.12T |
| Revenue (ttm) | 215.03B |
| Net Income (ttm) | 67.41B |
| Shares Out | n/a |
| EPS (ttm) | 260.87 |
| PE Ratio | 31.40 |
| Forward PE | 22.43 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8 |
| Average Volume | 283 |
| Open | 8,300.29 |
| Previous Close | 7,787.51 |
| Day's Range | 8,300.29 - 8,300.29 |
| 52-Week Range | 6,800.00 - 10,318.00 |
| Beta | 0.32 |
| RSI | 62.73 |
| Earnings Date | Feb 2, 2026 |